Rewalk Robotics Ltd  

(Public, NASDAQ:RWLK)   Watch this stock  
Find more results for RWLK
2.60
0.00 (0.00%)
Jan 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.60 - 2.70
52 week 2.55 - 12.20
Open 2.65
Vol / Avg. 156,454.00/231,360.00
Mkt cap 40.15M
P/E     -
Div/yield     -
EPS -2.53
Shares 16.33M
Beta     -
Inst. own 24%
Feb 23, 2017
Q4 2016 Rewalk Robotics Ltd Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 30, 2016
Rewalk Robotics Ltd at Piper Jaffray Healthcare Conference - Webcast
Nov 17, 2016
Rewalk Robotics Ltd at Canaccord Genuity Med Tech Conference
Nov 16, 2016
Rewalk Robotics Ltd at Jefferies Healthcare Conference
Nov 3, 2016
Q3 2016 Rewalk Robotics Ltd Earnings Release
Nov 3, 2016
Q3 2016 Rewalk Robotics Ltd Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -565.71% -678.46%
Operating margin -528.79% -672.02%
EBITD margin - -660.33%
Return on average assets -139.77% -69.40%
Return on average equity -498.23% -78.47%
Employees 87 -
CDP Score - -

Address

3 Hatnufa st. 6th fl., P.O. Box 161
YOKNEAM, 2069203
Israel
+972-4-9590123 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement. The Company's ReWalk designs focus on people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, who have the use of their upper bodies and arms. The Company offers various products, which include ReWalk Personal and ReWalk Rehabilitation. The Company's ReWalk Personal is designed for use by individuals at home and in their communities, and is custom-fit for each user. The Company's ReWalk Rehabilitation is designed for the clinical rehabilitation environment where it provides exercise and therapy.

Officers and directors

Kevin W. Hershberger Chief Financial Officer
Age: 51
Bio & Compensation  - Reuters
John Hamilton Vice President - Regulatory and Clinical
Age: 62
Bio & Compensation  - Reuters
Ofir Koren Vice President - Research & Development
Age: 46
Bio & Compensation  - Reuters
Jodi Gricci Vice President - Global Marketing and Training
Age: 48
Bio & Compensation  - Reuters
Jeff Dykan Independent Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Larry Jasinski Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Aryeh Dan Director
Age: 57
Bio & Compensation  - Reuters
Yasushi Ichiki Director
Age: 48
Bio & Compensation  - Reuters
Deborah DiSanzo Independent Director
Age: 56
Bio & Compensation  - Reuters
Glenn P. Muir Independent Director
Age: 57
Bio & Compensation  - Reuters